Elekta’s vision is to create a world where every patient has access to the highest standard of care. From the smallest tumor change to the toughest clinical decisions, Elekta sees every obstacle as an opportunity to progress.

For more than 50 years, Elekta has advanced precision in cancer care, and is now leading the way in making adaptive radiotherapy a practical standard of care for clinics everywhere. Since the start, Elekta has been dedicated to pioneering advances in cancer care and the treatment of brain disorders.

Further, key clinical studies show that adaptive radiotherapy:

• enables safer dose escalation, reduces toxicity, and helps preserve quality of life for prostate cancer patients
• improves precision, safety, and outcomes for gynecological cancers
• delivers precise, high-dose treatment safely, achieving meaningful local control and quality of life in pancreatic cancer